Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection

Journal of Pediatrics

Volumn 166, Issue 4, 2015, Pages 827-833

  Melvin, Ann J ^a   Mohan, Kathleen M ^a   Schiffer, Joshua T ^a,b   Drolette, Linda M ^a   Magaret, Amalia ^a,b   Corey, Lawrence ^a,b   Wald, Anna ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GLYCOPROTEIN B; VIRUS ANTIBODY; VIRUS DNA;

ANTIBODY BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID LEVEL; DISSEMINATED HERPES SIMPLEX; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; EYE INFECTION; FEMALE; HEPATITIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES SIMPLEX VIRUS 4; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH INFECTION; NEWBORN INFECTION; NEWBORN PERIOD; NONHUMAN; PEDIATRIC HOSPITAL; PLEOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SKIN INFECTION; VIRAL CLEARANCE; VIRUS CULTURE; VIRUS LOAD; BLOOD; CEREBROSPINAL FLUID; DISEASE COURSE; FOLLOW UP; GENETICS; ISOLATION AND PURIFICATION; NEWBORN; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SIMPLEXVIRUS; VIROLOGY;

CEREBROSPINAL FLUID; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HERPES SIMPLEX; HUMANS; INFANT; INFANT, NEWBORN; MALE; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SIMPLEXVIRUS;

EID: 84933280558     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.11.011     Document Type: Article

References (39)

1. Caviness AC, Demmler GJ, Swint JM, Cantor SB. Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates. Arch Pediatr Adolesc Med 2008;162:665-74.
2. Anzivino E, Fioriti D, Mischitelli M, Bellizzi A, Barucca V, Chiarini F, et al. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention. Virol J 2009;6:40.
3. Kimberlin DW. Diagnosis of herpes simplex virus in the era of polymerase chain reaction. Pediatr Infect Dis J 2006;25:841-2.
4. Cantey JB, Mejias A, Wallihan R, Doern C, Brock E, Salamon D, et al. Use of blood polymerase chain reaction testing for diagnosis of herpes simplex virus infection. J Pediatr 2012;161:357-61.
5. Kimberlin DW, Lakeman FD, Arvin AM, Prober CG, Corey L, Powell DA, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1996;174:1162-7.
6. Malm G, Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed 1999;81:F24-9.
7. Kimura H, Futamura M, Kito H, Ando T, Goto M, Kuzushima K, et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis 1991;164:289-93.
8. Kimura H, Ito Y, Futamura M, Ando Y, Yabuta Y, Hoshino Y, et al. Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J Med Virol 2002;67:349-53.
9. Diamond C,Mohan K,Hobson A, Frenkel L,Corey L. Viremia in neonatal herpes simplex virus infections. Pediatr Infect Dis J 1999;18:487-9.
10. Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991;324:444-9.
11. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988;26:662-7.
12. Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis 2003;30:310-4.
13. Langenberg A, Zbanyszek R, Dragavon J, Ashley R, Corey L. Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus. J Clin Microbiol 1988;26:1772-4.
14. Lafferty WE, Krofft S, Remington M, Giddings R, Winter C, Cent A, et al. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a highprevalence population. J Clin Microbiol 1987;25:323-6.
15. Jerome KR, Huang ML, Wald A, Selke S, Corey L. Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR. J Clin Microbiol 2002;40:2609-11.
16. Magaret AS, Wald A, Huang ML, Selke S, Corey L. Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa. J Clin Microbiol 2007;45:1618-20.
17. Corey L, Huang ML, Selke S, Wald A. Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay. J Med Virol 2005;76:350-5.
18. Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, GruberWC, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:230-8.
19. Kimberlin DW, Whitley RJ, Wan W, Powell DA, Storch G, Ahmed A, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 2011;365:1284-92.
20. Gantt S, Muller WJ. The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention. Clin Dev Immunol 2013;2013:369172.
21. Schiffer JT, Swan D, Al Sallaq R, Magaret A, Johnston C, Mark KE, et al. Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract. Elife 2013;2: e00288.
22. Zhu J, Hladik F,Woodward A, Klock A, Peng T, Johnston C, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanismfor increasedHIV-1 acquisition. NatMed 2009;15:886-92.
23. Zhu J, Peng T, Johnston C, Phasouk K, Kask AS, Klock A, et al. Immune surveillance by CD8alphaalpha+ skin-resident T cells in human herpes virus infection. Nature 2013;497:494-7.
24. Cunningham AL, Turner RR, Miller AC, Para MF, Merigan TC. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest 1985;75:226-33.
25. Filen F, Strand A, Allard A, Blomberg J, Herrmann B. Duplex real-time polymerase chain reaction assay for detection and quantification of herpes simplex virus type 1 and herpes simplex virus type 2 in genital and cutaneous lesions. Sex Transm Dis 2004;31:331-6.
26. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983;98:958-72.
27. Stanberry LR, Floyd-Reising SA, Connelly BL, Alter SJ, Gilchrist MJ, Rubio C, et al. Herpes simplex viremia: report of eight pediatric cases and review of the literature. Clin Infect Dis 1994;18:401-7.
28. Johnston C, Magaret A, Selke S, Remington M, Corey L, Wald A. Herpes simplex virus viremia during primary genital infection. J Infect Dis 2008; 198:31-4.
29. Berrington WR, Jerome KR, Cook L, Wald A, Corey L, Casper C. Clinical correlates of herpes simplex virus viremia among hospitalized adults. Clin Infect Dis 2009;49:1295-301.
30. Kimberlin DW, Baley J. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics 2013; 131:383-6.
31. Frenkel LM. Challenges in the diagnosis and management of neonatal herpes simplex virus encephalitis. Pediatrics 2005;115:795-7.
32. Wald A, Huang ML, Carrell D, Selke S, Corey L. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 2003; 188:1345-51.
33. Toth C, Harder S, Yager J. Neonatal herpes encephalitis: A case series and review of clinical presentation. Can J Neurol Sci 2003;30:36-40.
34. Lundberg P, Ramakrishna C, Brown J, Tyszka JM, Hamamura M, Hinton DR, et al. The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol 2008;82:7078-88.
35. Whitley RJ, Corey L, Arvin A, Lakeman FD, Sumaya CV, Wright PF, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988;158:109-16.
36. Kohl S, West MS, Prober CG, Sullender WM, Loo LS, Arvin AM. Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection. J Infect Dis 1989;160:770-6.
37. Corey L, Whitley RJ, Stone EF, Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet 1988;1:1-4.
38. Kohl S. A hypothesis on the pathophysiology of neonatal herpes simplex virus encephalitis: clinical recurrence after asymptomatic primary infection. Pediatr Infect Dis J 1990;9:307-8.
39. Ashley RL, Eagleton M, Pfeiffer N. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol 1999;37:1632-3.